Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-07 07:40 am Sale | 13G | 9 METERS BIOPHARMA INC NMTR | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -650,000 (Position Closed) | View |
| 2023-02-09 11:51 am Purchase | 13G | 9 METERS BIOPHARMA INC NMTR | ADAGE CAPITAL PARTNERS GP L.L.C. | 650,000 5.02% | 650,000 (New Position) | View |
| 2022-07-08 4:57 pm Sale | 13G | 9 METERS BIOPHARMA INC NMTR | BlackRock Inc. BLK | 3,370,798 1.3% | -10,794,003 (-76.20%) | View |
| 2022-07-01 5:20 pm Sale | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.6% | -3,027,545 (-19.68%) | View |
| 2022-02-10 10:35 am Purchase | 13G | 9 METERS BIOPHARMA INC NMTR | ADAGE CAPITAL PARTNERS GP L.L.C. | 15,000,000 5.87% | 2,000,000 (+15.38%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | 9 METERS BIOPHARMA INC NMTR | BlackRock Inc. BLK | 14,164,801 5.5% | 14,164,801 (New Position) | View |
| 2021-06-28 5:24 pm Sale | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 15,384,418 6% | -17,118,837 (-52.67%) | View |
| 2021-04-07 4:46 pm Unchanged | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 13.2% | 0 (Unchanged) | View |
| 2021-03-25 5:26 pm Unchanged | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 14.6% | 0 (Unchanged) | View |
| 2020-12-28 4:07 pm Purchase | 13G | 9 METERS BIOPHARMA INC NMTR | ADAGE CAPITAL PARTNERS GP L.L.C. | 13,000,000 6.41% | 13,000,000 (New Position) | View |
| 2020-12-16 5:13 pm Purchase | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 16% | 1,943,734 (+6.36%) | View |
| 2020-12-10 10:58 am Sale | 13G | 9 METERS BIOPHARMA INC NMTR | Capital Point Ltd. | 7,295,893 4.81% | -82,166 (-1.11%) | View |
| 2020-09-03 5:19 pm Purchase | 13G | 9 METERS BIOPHARMA INC NMTR | Capital Point Ltd. | 7,378,059 8.07% | 7,378,059 (New Position) | View |
| 2020-07-29 1:38 pm Unchanged | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 21.4% | 0 (Unchanged) | View |
| 2020-05-14 5:25 pm Purchase | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 27.3% | 30,559,521 (New Position) | View |